Improving Ambulation Post Stroke With Robotic Training

NCT ID: NCT00975156

Last Updated: 2013-02-25

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-05-31

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to look at a new rehabilitation technique for individuals who have suffered a stroke and have difficulties walking. This study is designed to compare robot-assisted (Lokomat) rehabilitation therapy with standard physical therapy in order to improve walking post-stroke. This research project will be conducted as a pilot randomized controlled trial that compares the effectiveness of Lokomat versus conventional physical therapy in improving the ambulation and gait of chronic stroke patients. The project will provide important pilot data that could indicate whether or not the effectiveness of Lokomat training is superior to that of standard physical therapy and if a definitive and larger clinical trial is warranted.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lokomat Intervention

Lokomat gait training (five days a week for eight weeks for a total of 40 sessions).

Group Type EXPERIMENTAL

Lokomat

Intervention Type DEVICE

Robotic-assisted walking device

Standard of Care

Conventional physical therapy focusing on gait training for five days a week for eight weeks for a total of 40 sessions.

Group Type ACTIVE_COMPARATOR

Physical Therapy

Intervention Type OTHER

Conventional physical therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physical Therapy

Conventional physical therapy

Intervention Type OTHER

Lokomat

Robotic-assisted walking device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with ischemic or hemorrhagic stroke confirmed by cerebral computed tomography (CT) or magnetic resonance imaging (MRI) scan
* Age\>18
* At least 3 months post stroke at time of enrollment into study
* Ability to walk at least 10 feet with maximum 1 person assist, but not to walk in the community independently
* Residual paresis in the lower extremity as defined by the National Institute of Health Stroke Scale lower extremity motor score 2-4
* Ability to perform Lokomat ambulation training with assistance of 1 therapist
* Ability to follow a three-step command
* Physician approval for patient participation
* Ability to give informed consent
* Completed their rehabilitation services, i.e., receiving no concurrent physical, occupational, or speech therapies

Exclusion Criteria

* Serious cardiac condition
* Uncontrolled blood pressure, defined as \> 200 or diastolic \> 100 at rest
* Hx of serious chronic obstructive pulmonary disease or oxygen dependence
* Sever weight bearing pain
* Lower extremity amputation
* Claudication while walking
* Life expectancy \< 1 year
* History of deep vein thrombosis/pulmonary embolism (DVT/PE) within 6 months
* Severe orthopedic problem
* Any medical or psychiatric condition that the investigators believe would make the patient unable to participate in this study
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Texas Health Science Center, Houston

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Elizabeth Noser

Clinical Assistant Professor - Neurology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elizabeth Noser, MD

Role: PRINCIPAL_INVESTIGATOR

The University of Texas Health Science Center, Houston

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Memorial Hermann

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Medallion Grant

Identifier Type: -

Identifier Source: secondary_id

HSC-MH-08-0206

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.